Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma

We designed a phase I/II trial of S-1 combined with weekly docetaxel to determine the maximum tolerated dose (MTD) and recommended dose (RD) and to evaluate the efficacy and toxicity in metastatic gastric carcinoma (MGC). Patients with measurable disease received S-1 orally b.i.d. on days 1–14 and d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Park, S R, Kim, H K, Kim, C G, Choi, I J, Lee, J S, Lee, J H, Ryu, K W, Kim, Y-W, Bae, J-M, Kim, N K
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2008
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361699/
https://ncbi.nlm.nih.gov/pubmed/18362939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604312
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados